TactiFlex™ Sensor Enabled™ A-TFSE-FJRecalls & reported problems
St. Jude Medical, Inc. · Ablation Catheter · Class 3
All models of TactiFlex Sensor Enabled (8)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
2 open recalls name this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 37
- Deaths reported
- 2
- Injuries reported
- 8
- Recalls naming it
- 2
Summary
The FDA's MAUDE database contains 37 adverse event reports that list this exact device (DI 05415067034618), received between Jan 10, 2024 and Mar 10, 2026 — classified as 2 deaths, 8 injuries, 27 malfunctions.
The most frequently reported specific device problem is “Communication or Transmission Problem” (11 reports).
2 FDA recall records name this device's identifier, 2 still open.
4 other recalls cover devices cleared under the same FDA submission (P220013); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Recalls naming this device
- Sep 10, 2025Open, Classified
Abbott has become aware of a limited number of tip detachment events during catheter removal from the packaging.
Z-0112-2026 · Root cause: Package design/selection · Recall details · FDA record ↗
- Dec 18, 2023Open, Classified
When the catheters are used with the EnSiteX EP System, the system does not correctly recognize the catheter as the appropriate product model and instead reads and displays it as a different model. This results in some features specific to the catheter do not appear on the display and the catheter image may also appear inverted.
Z-0814-2024 · Root cause: Under Investigation by firm · Recall details · FDA record ↗
Most reported problems
Device problems
- Communication or Transmission Problem11
- Adverse Event Without Identified Device or Use Problem9
- Optical Problem5
- Display or Visual Feedback Problem2
- Impedance Problem2
- Material Deformation2
- Material Separation2
- Use of Device Problem2
Patient problems
- No Clinical Signs, Symptoms or Conditions26
- Cardiac Perforation8
- Cardiac Tamponade1
- Insufficient Information1
- Perforation of Esophagus1
- Stroke/CVA1
Recent adverse event reports
The 25 most recent of 37 reports, in the reporter's own words as published by the FDA.
MalfunctionMar 10, 2026Material Separation; Communication or Transmission Problem
UPON PRODUCT INVESTIGATION, THE DISTAL TIP OF THE CATHETER WAS NOTED TO BE DETACHED, HOWEVER FURTHER INFORMATION RECEIVED FROM THE FIELD CONFIRMED THAT THE CATHETER WAS INTACT DURING DEVICE PREPARATION AND NEVER MADE PATIENT CONTACT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24560987 ↗MalfunctionMar 6, 2026Material Separation
DURING PRE-USE INSPECTION FOR AN SVT PROCEDURE, THE CATHETER TIP WAS FOUND TO BE FRACTURED AND DETACHED PRIOR TO PATIENT CONTACT. THE DEVICE WAS REPLACED, AND THE PROCEDURE WAS COMPLETED WITH NO ADVERSE CONSEQUENCES TO THE PATIENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24531030 ↗MalfunctionFeb 19, 2026Connection Problem
THIS REPORT INCLUDES CORRECTED DEVICE MANUFACTURING INFORMATION.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24387857 ↗InjuryJan 22, 2026Adverse Event Without Identified Device or Use Problem
AFTER THE REDO ATRIAL FIBRILLATION PROCEDURE WAS COMPLETED, A TRANSTHORACIC ECHOCARDIOGRAM WAS PERFORMED WHICH NOTED AN ABSENCE OF NORMAL CARDIAC SILHOUETTE MOVEMENT DUE TO A PERICARDIAL TAMPONADE. THIS RESULTED IN A PERICARDIOCENTESIS BEING PERFORMED. THE PATIENT BECAME HEMODYNAMICALLY STABLE. THE EXACT CAUSE OF THE TAMPONADE COULD NOT BE CLEARLY IDENTIFIED. DURING THE PROCEDURE, THERE WAS NO EXCESSIVE CONTACT FORCE OR ABNORMAL IMPEDANCE BEHAVIOR OBSERVED DURING RF ABLATIONS. THE ABLATION POWER SETTINGS WAS AT 50W. AS THIS WAS A REDO PROCEDURE, ABLATION WAS CARRIED OUT AT THE SUPERIOR VENA CAVA, ALONG THE LEFT SUPERIOR PULMONARY VEIN IN THE RIDGE AREA, AND THE RIGHT PULMONARY VEIN ANTRUM WAS WIDENED ON THE ANTERIOR ASPECT. THE LOCATION OF THE PERFORATION IS UNKNOWN. THE PATIENT IS STABLE. THERE WERE NO PERFORMANCE ISSUES WITH ANY ABBOTT DEVICE.
Patient problems: Cardiac Perforation
MAUDE report 24151608 ↗InjuryDec 26, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
DURING A VENTRICULAR TACHYCARDIA PROCEDURE, THE PATIENT EXPERIENCED A CARDIAC TAMPONADE WHICH REQUIRED A PERICARDIOCENTESIS. WHILE ADVANCING THE CATHETER INTO THE LEFT VENTRICLE, A DROP IN BLOOD PRESSURE AND POOR CONTRACTILITY IN THE CARDIAC SILHOUETTE WAS OBSERVED. FLUOROSCOPY AND AN ECHOCARDIOGRAM REVEALED A CARDIAC TAMPONADE. A PERICARDIOCENTESIS WAS PERFORMED TO STABILIZE THE PATIENT. THE PERFORATION WAS LOCATED IN THE AV GROOVE. THERE WAS NO PERFORMANCE ISSUE WITH ANY ABBOTT DEVICE. THE PHYSICIAN IS UNSURE WHAT CAUSED THE TAMPONADE.
Patient problems: Cardiac Perforation
MAUDE report 23896005 ↗MalfunctionNov 5, 2025Use of Device Problem; Use of Device Problem
DURING THE CAVO-TRICUSPID ISTHMUS PROCEDURE, THE ABLATION CATHETER WAS USED PAST ITS EXPIRATION DATE. THE ABLATION CATHETER WAS EXCHANGED AND THE PROCEDURE WAS COMPLETED WITH NO ADVERSE PATIENT CONSEQUENCES.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23480612 ↗MalfunctionSep 18, 2025Optical Problem; Optical Problem
DURING A SUPRAVENTRICULAR TACHYCARDIA PROCEDURE, THE ABLATION CATHETER WOULD NOT DISPLAY CONTACT FORCE. THE DEVICE WAS REPLACED, HOWEVER THE PROCEDURE WAS NOT COMPLETED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23083747 ↗MalfunctionSep 9, 2025Optical Problem; Optical Problem
THE CATHETER WOULD NOT DISPLAY CONTACT FORCE AND THE CASE WAS CANCELLED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23006194 ↗MalfunctionAug 27, 2025Use of Device Problem; Use of Device Problem
THIS REPORT IS TO ADVISE OF AN EXPIRED CATHETER USED DURING A PROCEDURE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22904756 ↗InjuryJul 18, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT DURING THE NIGHT FOLLOWING AN ATRIAL FIBRILLATION PROCEDURE, A PERICARDIAL EFFUSION WAS DIAGNOSED BY ECHOCARDIOGRAM. A PERICARDIOCENTESIS WAS PERFORMED TO STABILIZE THE PATIENT. THE CAUSE OF THE PERICARDIAL EFFUSION IS UNKNOWN.
Patient problems: Cardiac Perforation
MAUDE report 22542436 ↗InjuryJul 15, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
DURING A REDO ATRIAL FIBRILLATION PROCEDURE, A PERICARDIAL EFFUSION REQUIRING SURGERY TO RESOLVE. ABLATION WAS BEING PERFORMED ON THE INFERIOR ASPECT OF THE LIPV AND WHEN REACHING THE RIDGE, THE PATIENT BECAME HYPOTENSIVE. USING THE ICE CATHETER A PERICARDIAL EFFUSION AND A PERFORATION AT THE ANTERIOR SIDE OF THE LEFT ATRIAL APPENDAGE WAS CONFIRMED. A PERICARDIOCENTESIS WAS PERFORMED AND THE PATIENT WAS MOVED TO THE CORONARY UNIT TO BE MONITORED. HOURS LATER, THE BLEEDING HAD NOT STOPPED, SO THE PATIENT WAS TAKEN BACK FOR CARDIAC SURGERY. THE PATIENT HAS SINCE BEEN DISCHARGED. THERE WERE NO ALLEGED PERFORMANCE ISSUES WITH ANY ABBOTT DEVICES.
Patient problems: Cardiac Perforation
MAUDE report 22511608 ↗DeathJul 14, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
ONE MONTH FOLLOWING AN ATRIAL FIBRILLATION PROCEDURE, THE PATIENT EXPIRED DUE TO AN ESOPHAGEAL FISTULA. CAUSES AND CONTRIBUTING FACTORS ARE CURRENTLY UNKNOWN AND THERE HAS BEEN NO ALLEGED DEVICE INVOLVEMENT.
Patient problems: Perforation of Esophagus
MAUDE report 22501494 ↗DeathJun 20, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
DURING AN ATRIAL FIBRILLATION PROCEDURE, A PERICARDIAL EFFUSION OCCURRED AND THE PATIENT EXPIRED. AT THE END OF ABLATION THE PATIENT BECAME HYPOTENSIVE. AN ULTRASOUND CONFIRMED THE EFFUSION AND A PERICARDIOCENTESIS WAS PERFORMED STABILIZING THE PATIENT. THE PATIENT BECAME HYPOTENSIVE ONCE AGAIN A FEW MINUTES LATER AND CARDIAC MASSAGE WAS ATTEMPTED, HOWEVER, THE PATIENT EXPIRED. IT IS ALLEGED THAT THE PERICARDIAL EFFUSION MOST LIKELY OCCURRED DURING ABLATION WITH THE ABLATION CATHETER. THERE WERE NO ALLEGED PERFORMANCE ISSUES WITH ANY ABBOTT DEVICES.
Patient problems: Cardiac Perforation
MAUDE report 22298988 ↗MalfunctionJun 6, 2025Fracture; Fracture
THIS REPORT IS TO ADVISE OF A FRACTURE FOUND IN THE CATHETER DURING ANALYSIS.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22159670 ↗MalfunctionApr 3, 2025Optical Problem; Optical Problem
DURING A SUPRAVENTRICULAR TACHYCARDIA WITH ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA PROCEDURE, THE CATHETER FIBER OPTICS DID NOT DISPLAY CONTACT FORCE RESULTING IN A DELAY. THE TACISYS AND THE FIBER OPTICS CABLE WERE EXCHANGED, AND THE AMPERE GENERATOR WAS RESTARTED, WITH NO RESOLUTION. THE CATHETER WAS EXCHANGED, AND THE ISSUE WAS RESOLVED. THERE WERE NO ADVERSE PATIENT HEALTH CONSEQUENCES.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 21759357 ↗MalfunctionMar 24, 2025
ABLATION CATHETER STOPPED FLUSHING/REMOVED CATHETER AND OPENED NEW ABLATION CATHETER. NEW CATHETER WORKED PERFECTLY.
Patient problems: Insufficient Information
MAUDE report 21676063 ↗MalfunctionDec 2, 2024Optical Problem; Optical Problem
DURING A TYPICAL FLUTTER PROCEDURE, THE CATHETER DISPLAYED CONTACT FORCE ABOVE 100G RESULTING IN CANCELLATION OF THE PROCEDURE. THE CATHETER WAS RE-ZEROED, BUT ONCE IT MADE CONTACT WITH TISSUE, THE FORCE JUMPED TO OVER 100G. THE ISSUE WAS NOT RESOLVED, AND THE PROCEDURE WAS CANCELLED WITH NO PATIENT CONSEQUENCES.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 20823621 ↗MalfunctionNov 15, 2024Display or Visual Feedback Problem; Display or Visual Feedback Problem
RELATED MANUFACTURE REF: 3008452825-2024-00664. DURING AN ATRIAL FIBRILLATION PROCEDURE, AN OUTPUT ISSUE OCCURRED CAUSING A DELAY IN PROCEDURE. IT WAS NOTED THAT THERE WAS NO RF DELIVERY DURING ABLATION. THE TACTISYS CABLE AND AMPERE AMPLIFIER CABLE WERE EXCHANGED, AS WELL AS EXCHANGING THE TACTISYS AND GENERATOR WHICH DID NOT RESOLVE THE ISSUE. A SECOND CATHETER WAS OBTAINED, BUT IT COULD NOT BE VISUALIZED DESPITE SIGNALS BEING PRESENT. ADDITIONALLY, IT DISPLAYED A STRANGE SHAPE WHILE IN NAVX MODE. A THIRD CATHETER WAS THEN USED TO COMPLETE THE PROCEDURE WITH NO ADVERSE CONSEQUENCES TO THE PATIENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 20693930 ↗MalfunctionNov 15, 2024Failure to Deliver Energy; Failure to Deliver Energy
RELATED MANUFACTURE REF: 3008452825-2024-00665. DURING AN ATRIAL FIBRILLATION PROCEDURE, AN OUTPUT ISSUE OCCURRED CAUSING A DELAY IN PROCEDURE. IT WAS NOTED THAT THERE WAS NO RF DELIVERY DURING ABLATION. THE TACTISYS CABLE AND AMPERE AMPLIFIER CABLE WERE EXCHANGED, AS WELL AS EXCHANGING THE TACTISYS AND GENERATOR WHICH DID NOT RESOLVE THE ISSUE. A SECOND CATHETER WAS OBTAINED, BUT IT COULD NOT BE VISUALIZED DESPITE SIGNALS BEING PRESENT. ADDITIONALLY, IT DISPLAYED A STRANGE SHAPE WHILE IN NAVX MODE. A THIRD CATHETER WAS THEN USED TO COMPLETE THE PROCEDURE WITH NO ADVERSE CONSEQUENCES TO THE PATIENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 20693919 ↗InjuryNov 4, 2024Patient Device Interaction Problem; Patient Device Interaction Problem
DURING AN ABLATION OF THE CTI LINE IN THE RIGHT ATRIUM, A STEAM POP AND EFFUSION OCCURRED. WHILE ABLATING WITH 20W ON THE CAVO TRICUSPID ISTHMUS FOR 30 SEC EACH LESION, THE USER WAS UNABLE TO ACHIEVE BLOCK THE FIRST TIME AROUND, SO THE POWER WAS INCREASED TO 40W AND ABLATING AN AREA OF BREAKTHROUGH. AN AUDIBLE ¿POP¿ WAS HEARD, IMPEDANCE ROSE INSTANTLY FROM 105 OHMS TO 122 AND ABLATION WAS STOPPED. THE PATIENT THEN DEVELOPED AN EFFUSION AND INTERVENTION WAS APPLIED TO STABILIZE THE PATIENT.
Patient problems: Cardiac Perforation; Cardiac Tamponade
MAUDE report 20599488 ↗InjuryNov 1, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
DURING AN ATRIAL FIBRILLATION PROCEDURE, A CARDIAC TAMPONADE OCCURRED REQUIRING A PERICARDIOCENTESIS. AFTER ABLATION, AN APPENDIX OCCLUSION PROCEDURE WAS PERFORMED. AT THE END OF THE APPENDIX OCCLUSION PROCEDURE, WHEN THE PUNCTURE COMPRESSION WAS BEING PERFORMED, EVIDENCE OF A CARDIAC TAMPONADE WAS IDENTIFIED. A PERICARDIOCENTESIS WAS PERFORMED, AND THE PATIENT REMAINED STABLE WITHOUT FURTHER COMPLICATIONS. THERE WERE NO ALLEGED PERFORMANCE ISSUES WITH ANY ABBOTT DEVICES.
Patient problems: Cardiac Perforation
MAUDE report 20588502 ↗InjuryOct 18, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
DURING A LEFT-SIDED ATRIAL TACHYCARDIA PROCEDURE, THE PHYSICIAN WAS APPLYING RADIOFREQUENCY WITH TACTIFLEX. WHEN THE PROCEDURE WAS ABOUT TO FINISH, CARDIAC TAMPONADE OCCURRED DUE TO THE ABLATION AND THE PATIENT HAD TO BE TREATED. PATIENT IS CURRENTLY STABLE. CATHETER WAS DISCARDED.
Patient problems: Cardiac Perforation
MAUDE report 20482207 ↗MalfunctionJun 13, 2024Material Deformation; Material Deformation
THIS REPORT IS TO ADVISE OF A DISPLACED ELECTRODE FOUND DURING ANALYSIS.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19531161 ↗MalfunctionMay 3, 2024Material Deformation; Material Deformation
THIS REPORT IS TO ADVISE OF A DISPLACED ELECTRODE NOTED DURING ANALYSIS.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19238399 ↗MalfunctionApr 17, 2024Communication or Transmission Problem; Impedance Problem; Communication or Transmission Problem; Impedance Problem
DURING A RIGHT ATRIAL FLUTTER PROCEDURE, AN ERROR MESSAGE OCCURRED CAUSING A PROCEDURE DELAY. THE CATHETER WAS CONNECTED TO THE GENERATOR WITH AN IMPEDANCE READING OF APPROXIMATELY 100 OHMS, AND AN ERROR MESSAGE WAS NOTED STATING: "CATHETER NOT CONNECTED". THIS ERROR APPEARED WITH TWO DIFFERENT AMPERE GENERATORS. THE CATHETER WAS EXCHANGED WHICH DID NOT RESOLVE THE ISSUE. THE TACTIFLEX CATHETER WAS REPLACED WITH A TACTICATH SE BUT THE ISSUE WAS NOT RESOLVED. THE ENSITE X WAS THEN SWITCHED TO ENSITE PRECISION, WHICH RESOLVED THE ISSUE WITH NO CONSEQUENCES TO THE PATIENT. IT SHOULD BE NOTED THAT THE ENSITE X HAS BEEN USED SINCE WITH NO ISSUES NOTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19124339 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P220013. One submission often covers many models, so check the product and lot details in each record.
- Z-0113-2026 · Sep 10, 2025 · Open, ClassifiedTactiFlex Sensor Enabled Ablation Catheter, 8F, 115 cm, F, (UniD Curve F), REF A-TFSE-F; cardiac catheter
- Z-0110-2026 · Sep 10, 2025 · Open, ClassifiedTactiFlex Sensor Enabled Ablation Catheter, 8F, 115 cm, DD, (BiD Curve D-D), REF A-TFSE-DD; cardiac catheter
- Z-0111-2026 · Sep 10, 2025 · Open, ClassifiedTactiFlex Sensor Enabled Ablation Catheter, 8F, 115 cm, DF, (BiD Curve D-F), REF A-TFSE-DF; cardiac catheter
- Z-0109-2026 · Sep 10, 2025 · Open, ClassifiedTactiFlex Sensor Enabled Ablation Catheter, 8F, 115 cm, D, (UniD Curve D), REF A-TFSE-D; cardiac catheter
Other Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation devices
- TactiCath™ A-TCSE-DFSt. Jude Medical, Inc. · Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation1 recall23 deaths923 reports
- TactiCath™ PN-004075St. Jude Medical, Inc. · Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation7 deaths338 reports
- TactiFlex™ Sensor Enabled™ A-TFSE-DFSt. Jude Medical, Inc. · Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation1 recall6 deaths241 reports
- TactiCath™ A-TCSE-FJSt. Jude Medical, Inc. · Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation1 recall3 deaths174 reports
- Sphere-9™ Catheter AFR-00001Medtronic, Inc. · Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation1 recall3 deaths147 reports
- TactiCath™ A-TCSE-DSt. Jude Medical, Inc. · Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation2 deaths175 reports
- TactiSys™ PN-004400St. Jude Medical, Inc. · Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation1 recall125 reports
- QDOT MICRO D139402Biosense Webster Inc · Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation3 deaths171 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page